Receptor cleavage reduces the fluid shear response in neutrophils of the spontaneously hypertensive rat

American Journal of Physiology - Cell Physiology

Volumn 299, Issue 6, 2010, Pages

  Chen, Angela Y ^a   DeLano, Frank A ^a   Valdez, Shakti R ^a   Ha, Jessica N ^a   Shin, Hainsworth Y ^b   Schmid Schönbein, Geert W ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cone and plate device; Formyl peptide receptor; Immunohistochemistry; N formyl methionine leucine phenylalanine; Pseudopod projection

Indexed keywords

DOXYCYCLINE; FORMYLPEPTIDE RECEPTOR; GELATINASE B; MATRIX METALLOPROTEINASE; MEMBRANE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DENSITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ESSENTIAL HYPERTENSION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT; SHEAR STRESS; WISTAR KYOTO RAT;

ANIMALS; DOXYCYCLINE; HYPERTENSION; MALE; MATRIX METALLOPROTEINASE 9; NEUTROPHILS; PSEUDOPODIA; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, FORMYL PEPTIDE; SHEAR STRENGTH; STRESS, MECHANICAL;

PSEUDOPODA; RATTUS; RATTUS NORVEGICUS;

EID: 78649659493     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00157.2010     Document Type: Article

References (45)

1. Abdulla MH, O'Brien T, Mackey ZB, Sajid M, Grab DJ, McKerrow JH. RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model. PLoS Negl Trop Dis 2: e298, 2008.
2. Barr TL, Latour LL, Lee KY, Schaewe TJ, Luby M, Chang GS, El-Zammar Z, Alam S, Hallenbeck JM, Kidwell CS, Warach S. Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke 41: e123-e128, 2009.
3. Boz C, Ozmenoglu M, Velioglu S, Kilinc K, Orem A, Alioglu Z, Altunayoglu V. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta. Clin Neurol Neurosurg 108: 124-128, 2006.
4. DeLano FA, Schmid-Schönbein GW. Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat. Hypertension 52: 415-423, 2008.
5. DeLano FA, Zhang H, Tran EE, Zhang C, Schmid-Schönbein GW. New hypothesis for insulin resistance in hypertension due to receptor cleavage. Expert Rev Endocrinol Metab 5: 149-158, 2010.
6. Friese RS, Rao F, Khandrika S, Thomas B, Ziegler MG, Schmid- Schönbein GW, O'Connor DT. Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease. Clin Exp Hypertens 31: 521-533, 2009.
7. Fukuda S, Schmid-Schönbein GW. Centrifugation attenuates the fluid shear response of circulating leukocytes. J Leukoc Biol 72: 133-139, 2002.
8. Fukuda S, Schmid-Schönbein GW. Regulation of CD18 expression on neutrophils in response to fluid shear stress. Proc Natl Acad Sci USA 100: 13152-13157, 2003.
9. Fukuda S, Yasu T, Kobayashi N, Ikeda N, Schmid-Schönbein GW. Contribution of fluid shear response in leukocytes to hemodynamic resistance in the spontaneously hypertensive rat. Circ Res 95: 100-108, 2004.
10. Fukuda S, Yasu T, Predescu DN, Schmid-Schönbein GW. Mechanisms for regulation of fluid shear stress response in circulating leukocytes. Circ Res 86: E13-18, 2000.
11. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, Dominiczak AF. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37: 529-534, 2001.
12. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 33: 1353-1358, 1999.
13. Kimoto S, Nishida S, Funasaka K, Nakano T, Teramoto K, Tomura TT. Regional distribution of superoxide dismutase in the brain and myocardium of the stroke-prone spontaneously hypertensive rat. Clin Exp Pharmacol Physiol Suppl 22: S160-S161, 1995.
14. Komai Y, Schmid-Schönbein GW. De-activation of neutrophils in suspension by fluid shear stress: a requirement for erythrocytes. Ann Biomed Eng 33: 1375-1386, 2005.
15. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 23: 541-548, 2002.
16. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169: 681-691, 2005.
17. Levy AS, Chung JC, Kroetsch JT, Rush JW. Nitric oxide and coronary vascular endothelium adaptations in hypertension. Vasc Health Risk Manag 5: 1075-1087, 2009.
18. Loitto VM, Rasmusson B, Magnusson KE. Assessment of neutrophil N-formyl peptide receptors by using antibodies and fluorescent peptides. J Leukoc Biol 69: 762-771, 2001.
19. Lominadze D, Joshua IG, Schuschke DA. Increased erythrocyte aggregation in spontaneously hypertensive rats. Am J Hypertens 11: 784-789, 1998. (Pubitemid 28351010)
20. Makino A, Glogauer M, Bokoch GM, Chien S, Schmid-Schönbein GW. Control of neutrophil pseudopods by fluid shear: role of Rho family GTPases. Am J Physiol Cell Physiol 288: C863-C871, 2005.
21. Makino A, Prossnitz ER, Bunemann M, Wang JM, Yao W, Schmid-Schönbein GW. G protein-coupled receptors serve as mechanosensors for fluid shear stress in neutrophils. Am J Physiol Cell Physiol 290: C1633-C1639, 2006.
22. Makino A, Shin HY, Komai Y, Fukuda S, Coughlin M, Sugihara-Seki M, Schmid-Schönbein GW. Mechanotransduction in leukocyte activation: a review. Biorheology 44: 221-249, 2007.
23. Marasco WA, Fantone JC, Freer RJ, Ward PA. Characterization of the rat neutrophil formyl peptide chemotaxis receptor. Am J Pathol 111: 273-281, 1983.
24. Marschel P, Schmid-Schönbein GW. Control of fluid shear response in circulating leukocytes by integrins. Ann Biomed Eng 30: 333-343, 2002.
25. Mendoza V, Vilchis-Landeros MM, Mendoza-Hernandez G, Huang T, Villarreal MM, Hinck AP, Lopez-Casillas F, Montiel JL. Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor. Biochemistry 48: 11755-11765, 2009.
26. Moazzam F, DeLano FA, Zweifach BW, Schmid-Schönbein GW. The leukocyte response to fluid stress. Proc Natl Acad Sci USA 94: 5338-5343, 1997.
27. Panaro MA, Cianciulli A, Lisi S, Sisto M, Acquafredda A, Mitolo V. Formyl peptide receptor expression in birds. Immunopharmacol Immunotoxicol 29: 1-16, 2007.
28. Pliyev BK, Menshikov MY. Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis. Inflammation 33: 1-9, 2010.
29. Plotnikov MB, Aliev OI, Koltunov AA, Maslov MY. Blood hyperviscosity syndrome: adequacy of experimental model in SHR rats. Bull Exp Biol Med 126: 775-776, 1998.
30. 2-adrenergic receptor in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 299: H25-H35, 2010.
31. Schmid-Schönbein GW, Zweifach BW, Moazzam F. Mechanisms of leukocyte activation in the circulation. Atherosclerosis 131 Suppl: S23-S25, 1997.
32. Shin HY, Simon SI, Schmid-Schönbein GW. Fluid shear-induced activation and cleavage of CD18 during pseudopod retraction by human neutrophils. J Cell Physiol 214: 528-536, 2008.
33. Su SS, Schmid-Schönbein GW. Fluid stresses on the membrane of migrating leukocytes. Ann Biomed Eng 36: 298-307, 2008.
34. Suematsu M, Suzuki H, Tamatani T, Iigou Y, DeLano FA, Miyasaka M, Forrest MJ, Kannagi R, Zweifach BW, Ishimura Y, Schmid-Schönbein GW. Impairment of selectin-mediated leukocyte adhesion to venular endothelium in spontaneously hypertensive rats. J Clin Invest 96: 2009-2016, 1995.
35. Sugihara-Seki M, Schmid-Schönbein GW. The fluid shear stress distribution on the membrane of leukocytes in the microcirculation. J Biomech Eng 125: 628-638, 2003.
36. The Soluble Insulin Receptor Study Group. Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes. Diabetes 56: 2028-2035, 2007.
37. The UniProt Consortium. The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res 38: D142-D148, 2010.
38. Thrailkill K, Cockrell G, Simpson P, Moreau C, Fowlkes J, Bunn RC. Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens. Clin Chem Lab Med 44: 503-504, 2006.
39. Tran ED, DeLano FA, Schmid-Schönbein GW. Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction. J Vasc Res 47: 423-431, 2010.
40. Turk BE, Huang LL, Piro ET, Cantley LC. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat Biotechnol 19: 661-667, 2001.
41. Watts RG, Crispens MA, Howard TH. A quantitative study of the role of F-actin in producing neutrophil shape. Cell Motil Cytoskeleton 19: 159-168, 1991.
42. Yang AL, Yeh CK, Su CT, Lo CW, Lin KL, Lee SD. Aerobic exercise acutely improves insulin- and insulin-like growth factor-1-mediated vasorelaxation in hypertensive rats. Exp Physiol 95: 622-629. 2010.
43. Zhan CD, Sindhu RK, Pang J, Ehdaie A, Vaziri ND. Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet. J Hypertens 22: 2025-2033, 2004.
44. i and microvessel permeability in the absence of adhesion: role of reactive oxygen species. Am J Physiol Heart Circ Physiol 288: H1331-H1338, 2005.
45. Zhu L, He P. fMLP-stimulated release of reactive oxygen species from adherent leukocytes increases microvessel permeability. Am J Physiol Heart Circ Physiol 290: H365-H372, 2006.